nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—prostate cancer—bone cancer	0.585	1	CtDrD
Prednisone—CYP3A4—bone cancer	0.261	1	CbGaD
Prednisone—SLCO1A2—Methotrexate—bone cancer	0.0263	0.377	CbGbCtD
Prednisone—ALB—Methotrexate—bone cancer	0.0136	0.195	CbGbCtD
Prednisone—ABCB1—Cisplatin—bone cancer	0.0109	0.157	CbGbCtD
Prednisone—ABCB1—Doxorubicin—bone cancer	0.00733	0.105	CbGbCtD
Prednisone—ABCB1—Methotrexate—bone cancer	0.0071	0.102	CbGbCtD
Prednisone—CYP3A4—Doxorubicin—bone cancer	0.00439	0.0631	CbGbCtD
Prednisone—NR3C1—Signaling events mediated by HDAC Class II—BCOR—bone cancer	0.000371	0.0685	CbGpPWpGaD
Prednisone—HSD11B1—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.000358	0.066	CbGpPWpGaD
Prednisone—Exemestane—CYP3A4—bone cancer	0.000291	0.0981	CrCbGaD
Prednisone—Hydrocortamate—CYP3A4—bone cancer	0.000217	0.0732	CrCbGaD
Prednisone—Cortisone acetate—CYP3A4—bone cancer	0.000214	0.072	CrCbGaD
Prednisone—Budesonide—CYP3A4—bone cancer	0.000202	0.068	CrCbGaD
Prednisone—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000185	0.0341	CbGpPWpGaD
Prednisone—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000181	0.0334	CbGpPWpGaD
Prednisone—NR3C1—Signaling events mediated by HDAC Class II—TUBB2A—bone cancer	0.000176	0.0324	CbGpPWpGaD
Prednisone—Alclometasone—CYP3A4—bone cancer	0.000174	0.0586	CrCbGaD
Prednisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—bone cancer	0.000173	0.0319	CbGpPWpGaD
Prednisone—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00017	0.0313	CbGpPWpGaD
Prednisone—Flunisolide—CYP3A4—bone cancer	0.00017	0.0571	CrCbGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000169	0.0312	CbGpPWpGaD
Prednisone—Paramethasone—CYP3A4—bone cancer	0.000167	0.0564	CrCbGaD
Prednisone—NR3C1—Nuclear Receptors—NR1I2—bone cancer	0.000166	0.0306	CbGpPWpGaD
Prednisone—Ciclesonide—CYP3A4—bone cancer	0.000165	0.0554	CrCbGaD
Prednisone—ALB—Folate Metabolism—FOLR1—bone cancer	0.000164	0.0303	CbGpPWpGaD
Prednisone—Fluorometholone—CYP3A4—bone cancer	0.000163	0.055	CrCbGaD
Prednisone—Vascular purpura—Epirubicin—bone cancer	0.000162	0.00215	CcSEcCtD
Prednisone—Sepsis—Doxorubicin—bone cancer	0.00016	0.00213	CcSEcCtD
Prednisone—Vision blurred—Cisplatin—bone cancer	0.00016	0.00213	CcSEcCtD
Prednisone—Cardiac failure congestive—Epirubicin—bone cancer	0.00016	0.00212	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—FEV—bone cancer	0.000158	0.0292	CbGpPWpGaD
Prednisone—Lethargy—Methotrexate—bone cancer	0.000158	0.0021	CcSEcCtD
Prednisone—Methylprednisolone—CYP3A4—bone cancer	0.000158	0.0532	CrCbGaD
Prednisone—Ill-defined disorder—Cisplatin—bone cancer	0.000158	0.0021	CcSEcCtD
Prednisone—Anaemia—Cisplatin—bone cancer	0.000157	0.00209	CcSEcCtD
Prednisone—Thrombophlebitis—Doxorubicin—bone cancer	0.000155	0.00206	CcSEcCtD
Prednisone—Osteoarthritis—Methotrexate—bone cancer	0.000155	0.00206	CcSEcCtD
Prednisone—Increased appetite—Epirubicin—bone cancer	0.000154	0.00205	CcSEcCtD
Prednisone—Diabetes mellitus—Doxorubicin—bone cancer	0.000154	0.00205	CcSEcCtD
Prednisone—Malaise—Cisplatin—bone cancer	0.000153	0.00204	CcSEcCtD
Prednisone—Purpura—Epirubicin—bone cancer	0.000151	0.002	CcSEcCtD
Prednisone—Vascular purpura—Doxorubicin—bone cancer	0.00015	0.00199	CcSEcCtD
Prednisone—Cardiac failure—Epirubicin—bone cancer	0.000149	0.00197	CcSEcCtD
Prednisone—Lethargy—Epirubicin—bone cancer	0.000148	0.00197	CcSEcCtD
Prednisone—Cardiac failure congestive—Doxorubicin—bone cancer	0.000148	0.00196	CcSEcCtD
Prednisone—Irritability—Methotrexate—bone cancer	0.000148	0.00196	CcSEcCtD
Prednisone—Convulsion—Cisplatin—bone cancer	0.000147	0.00196	CcSEcCtD
Prednisone—Mood swings—Methotrexate—bone cancer	0.000147	0.00195	CcSEcCtD
Prednisone—Osteoarthritis—Epirubicin—bone cancer	0.000145	0.00193	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.000145	0.00193	CcSEcCtD
Prednisone—Myalgia—Cisplatin—bone cancer	0.000145	0.00192	CcSEcCtD
Prednisone—Anxiety—Cisplatin—bone cancer	0.000144	0.00192	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000144	0.00191	CcSEcCtD
Prednisone—Discomfort—Cisplatin—bone cancer	0.000143	0.0019	CcSEcCtD
Prednisone—Increased appetite—Doxorubicin—bone cancer	0.000143	0.0019	CcSEcCtD
Prednisone—Affect lability—Epirubicin—bone cancer	0.000143	0.0019	CcSEcCtD
Prednisone—Face oedema—Epirubicin—bone cancer	0.00014	0.00186	CcSEcCtD
Prednisone—Purpura—Doxorubicin—bone cancer	0.000139	0.00185	CcSEcCtD
Prednisone—Anaphylactic shock—Cisplatin—bone cancer	0.000139	0.00184	CcSEcCtD
Prednisone—Oedema—Cisplatin—bone cancer	0.000139	0.00184	CcSEcCtD
Prednisone—Cardiac arrest—Epirubicin—bone cancer	0.000138	0.00183	CcSEcCtD
Prednisone—Infection—Cisplatin—bone cancer	0.000138	0.00183	CcSEcCtD
Prednisone—Cardiac failure—Doxorubicin—bone cancer	0.000138	0.00183	CcSEcCtD
Prednisone—Mood swings—Epirubicin—bone cancer	0.000137	0.00182	CcSEcCtD
Prednisone—Lethargy—Doxorubicin—bone cancer	0.000137	0.00182	CcSEcCtD
Prednisone—Nervous system disorder—Cisplatin—bone cancer	0.000136	0.00181	CcSEcCtD
Prednisone—Tachycardia—Cisplatin—bone cancer	0.000136	0.0018	CcSEcCtD
Prednisone—Skin disorder—Cisplatin—bone cancer	0.000135	0.00179	CcSEcCtD
Prednisone—Osteoarthritis—Doxorubicin—bone cancer	0.000134	0.00178	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000134	0.00178	CcSEcCtD
Prednisone—Hyperhidrosis—Cisplatin—bone cancer	0.000134	0.00178	CcSEcCtD
Prednisone—Danazol—CYP3A4—bone cancer	0.000134	0.0451	CrCbGaD
Prednisone—Triamcinolone—CYP3A4—bone cancer	0.000133	0.0448	CrCbGaD
Prednisone—Dry skin—Epirubicin—bone cancer	0.000133	0.00177	CcSEcCtD
Prednisone—Anorexia—Cisplatin—bone cancer	0.000132	0.00176	CcSEcCtD
Prednisone—Affect lability—Doxorubicin—bone cancer	0.000132	0.00175	CcSEcCtD
Prednisone—Hypokalaemia—Epirubicin—bone cancer	0.000132	0.00175	CcSEcCtD
Prednisone—Pancreatitis—Methotrexate—bone cancer	0.000131	0.00174	CcSEcCtD
Prednisone—NR3C1—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.000131	0.0242	CbGpPWpGaD
Prednisone—Triamcinolone—PTGS2—bone cancer	0.00013	0.0439	CrCbGaD
Prednisone—Face oedema—Doxorubicin—bone cancer	0.00013	0.00172	CcSEcCtD
Prednisone—Muscular weakness—Epirubicin—bone cancer	0.000128	0.0017	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000128	0.0017	CcSEcCtD
Prednisone—Cardiac arrest—Doxorubicin—bone cancer	0.000128	0.00169	CcSEcCtD
Prednisone—Mood swings—Doxorubicin—bone cancer	0.000127	0.00169	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000127	0.00168	CcSEcCtD
Prednisone—Abdominal distension—Epirubicin—bone cancer	0.000126	0.00168	CcSEcCtD
Prednisone—Neutropenia—Methotrexate—bone cancer	0.000125	0.00166	CcSEcCtD
Prednisone—Paraesthesia—Cisplatin—bone cancer	0.000125	0.00166	CcSEcCtD
Prednisone—Erectile dysfunction—Methotrexate—bone cancer	0.000123	0.00164	CcSEcCtD
Prednisone—Dry skin—Doxorubicin—bone cancer	0.000123	0.00163	CcSEcCtD
Prednisone—Pancreatitis—Epirubicin—bone cancer	0.000123	0.00163	CcSEcCtD
Prednisone—Hypokalaemia—Doxorubicin—bone cancer	0.000122	0.00162	CcSEcCtD
Prednisone—Decreased appetite—Cisplatin—bone cancer	0.000121	0.0016	CcSEcCtD
Prednisone—HSD11B1—Metabolism—NDUFA12—bone cancer	0.00012	0.0221	CbGpPWpGaD
Prednisone—Depression—Methotrexate—bone cancer	0.000119	0.00158	CcSEcCtD
Prednisone—Muscular weakness—Doxorubicin—bone cancer	0.000118	0.00157	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000118	0.00157	CcSEcCtD
Prednisone—Neutropenia—Epirubicin—bone cancer	0.000117	0.00156	CcSEcCtD
Prednisone—Abdominal distension—Doxorubicin—bone cancer	0.000117	0.00155	CcSEcCtD
Prednisone—Feeling abnormal—Cisplatin—bone cancer	0.000114	0.00152	CcSEcCtD
Prednisone—Weight increased—Epirubicin—bone cancer	0.000114	0.00151	CcSEcCtD
Prednisone—Pancreatitis—Doxorubicin—bone cancer	0.000114	0.00151	CcSEcCtD
Prednisone—Weight decreased—Epirubicin—bone cancer	0.000113	0.00151	CcSEcCtD
Prednisone—Hyperglycaemia—Epirubicin—bone cancer	0.000113	0.0015	CcSEcCtD
Prednisone—Methyltestosterone—CYP3A4—bone cancer	0.000113	0.0381	CrCbGaD
Prednisone—Prednisolone—CYP3A4—bone cancer	0.000111	0.0375	CrCbGaD
Prednisone—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000111	0.0205	CbGpPWpGaD
Prednisone—Body temperature increased—Cisplatin—bone cancer	0.00011	0.00146	CcSEcCtD
Prednisone—Neuropathy peripheral—Epirubicin—bone cancer	0.00011	0.00145	CcSEcCtD
Prednisone—Betamethasone—CYP3A4—bone cancer	0.000109	0.0367	CrCbGaD
Prednisone—Neutropenia—Doxorubicin—bone cancer	0.000108	0.00144	CcSEcCtD
Prednisone—Haemoglobin—Methotrexate—bone cancer	0.000108	0.00143	CcSEcCtD
Prednisone—Haemorrhage—Methotrexate—bone cancer	0.000107	0.00142	CcSEcCtD
Prednisone—Betamethasone—PTGS2—bone cancer	0.000107	0.036	CrCbGaD
Prednisone—Weight increased—Doxorubicin—bone cancer	0.000106	0.0014	CcSEcCtD
Prednisone—Weight decreased—Doxorubicin—bone cancer	0.000105	0.00139	CcSEcCtD
Prednisone—Hyperglycaemia—Doxorubicin—bone cancer	0.000105	0.00139	CcSEcCtD
Prednisone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000105	0.0193	CbGpPWpGaD
Prednisone—Hypersensitivity—Cisplatin—bone cancer	0.000102	0.00136	CcSEcCtD
Prednisone—Bradycardia—Epirubicin—bone cancer	0.000102	0.00136	CcSEcCtD
Prednisone—Neuropathy peripheral—Doxorubicin—bone cancer	0.000101	0.00135	CcSEcCtD
Prednisone—Haemoglobin—Epirubicin—bone cancer	0.000101	0.00134	CcSEcCtD
Prednisone—Haemorrhage—Epirubicin—bone cancer	0.0001	0.00133	CcSEcCtD
Prednisone—Eye disorder—Methotrexate—bone cancer	0.0001	0.00133	CcSEcCtD
Prednisone—Asthenia—Cisplatin—bone cancer	9.96e-05	0.00132	CcSEcCtD
Prednisone—HSD11B1—Metabolism—NT5C3A—bone cancer	9.91e-05	0.0183	CbGpPWpGaD
Prednisone—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	9.91e-05	0.0183	CbGpPWpGaD
Prednisone—Connective tissue disorder—Epirubicin—bone cancer	9.86e-05	0.00131	CcSEcCtD
Prednisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	9.74e-05	0.018	CbGpPWpGaD
Prednisone—Angiopathy—Methotrexate—bone cancer	9.73e-05	0.00129	CcSEcCtD
Prednisone—Immune system disorder—Methotrexate—bone cancer	9.69e-05	0.00129	CcSEcCtD
Prednisone—Diarrhoea—Cisplatin—bone cancer	9.5e-05	0.00126	CcSEcCtD
Prednisone—Alopecia—Methotrexate—bone cancer	9.48e-05	0.00126	CcSEcCtD
Prednisone—Bradycardia—Doxorubicin—bone cancer	9.45e-05	0.00125	CcSEcCtD
Prednisone—Mental disorder—Methotrexate—bone cancer	9.4e-05	0.00125	CcSEcCtD
Prednisone—Eye disorder—Epirubicin—bone cancer	9.38e-05	0.00125	CcSEcCtD
Prednisone—Malnutrition—Methotrexate—bone cancer	9.34e-05	0.00124	CcSEcCtD
Prednisone—Erythema—Methotrexate—bone cancer	9.34e-05	0.00124	CcSEcCtD
Prednisone—Haemoglobin—Doxorubicin—bone cancer	9.33e-05	0.00124	CcSEcCtD
Prednisone—Flushing—Epirubicin—bone cancer	9.31e-05	0.00124	CcSEcCtD
Prednisone—Haemorrhage—Doxorubicin—bone cancer	9.29e-05	0.00123	CcSEcCtD
Prednisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—bone cancer	9.26e-05	0.0171	CbGpPWpGaD
Prednisone—Connective tissue disorder—Doxorubicin—bone cancer	9.13e-05	0.00121	CcSEcCtD
Prednisone—Angiopathy—Epirubicin—bone cancer	9.11e-05	0.00121	CcSEcCtD
Prednisone—Immune system disorder—Epirubicin—bone cancer	9.07e-05	0.0012	CcSEcCtD
Prednisone—Arrhythmia—Epirubicin—bone cancer	8.97e-05	0.00119	CcSEcCtD
Prednisone—CYP2C19—Xenobiotics—CYP3A4—bone cancer	8.92e-05	0.0164	CbGpPWpGaD
Prednisone—Alopecia—Epirubicin—bone cancer	8.87e-05	0.00118	CcSEcCtD
Prednisone—Vomiting—Cisplatin—bone cancer	8.83e-05	0.00117	CcSEcCtD
Prednisone—Vision blurred—Methotrexate—bone cancer	8.8e-05	0.00117	CcSEcCtD
Prednisone—Mental disorder—Epirubicin—bone cancer	8.79e-05	0.00117	CcSEcCtD
Prednisone—Rash—Cisplatin—bone cancer	8.75e-05	0.00116	CcSEcCtD
Prednisone—Dermatitis—Cisplatin—bone cancer	8.75e-05	0.00116	CcSEcCtD
Prednisone—Malnutrition—Epirubicin—bone cancer	8.74e-05	0.00116	CcSEcCtD
Prednisone—Erythema—Epirubicin—bone cancer	8.74e-05	0.00116	CcSEcCtD
Prednisone—Eye disorder—Doxorubicin—bone cancer	8.68e-05	0.00115	CcSEcCtD
Prednisone—Ill-defined disorder—Methotrexate—bone cancer	8.66e-05	0.00115	CcSEcCtD
Prednisone—Anaemia—Methotrexate—bone cancer	8.63e-05	0.00115	CcSEcCtD
Prednisone—Flushing—Doxorubicin—bone cancer	8.62e-05	0.00114	CcSEcCtD
Prednisone—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	8.57e-05	0.0158	CbGpPWpGaD
Prednisone—Hydrocortisone—CYP3A4—bone cancer	8.52e-05	0.0287	CrCbGaD
Prednisone—Angiopathy—Doxorubicin—bone cancer	8.43e-05	0.00112	CcSEcCtD
Prednisone—Malaise—Methotrexate—bone cancer	8.42e-05	0.00112	CcSEcCtD
Prednisone—Immune system disorder—Doxorubicin—bone cancer	8.39e-05	0.00111	CcSEcCtD
Prednisone—Vertigo—Methotrexate—bone cancer	8.39e-05	0.00111	CcSEcCtD
Prednisone—Arrhythmia—Doxorubicin—bone cancer	8.3e-05	0.0011	CcSEcCtD
Prednisone—Nausea—Cisplatin—bone cancer	8.25e-05	0.00109	CcSEcCtD
Prednisone—Vision blurred—Epirubicin—bone cancer	8.23e-05	0.00109	CcSEcCtD
Prednisone—Alopecia—Doxorubicin—bone cancer	8.21e-05	0.00109	CcSEcCtD
Prednisone—Mental disorder—Doxorubicin—bone cancer	8.14e-05	0.00108	CcSEcCtD
Prednisone—Ill-defined disorder—Epirubicin—bone cancer	8.11e-05	0.00108	CcSEcCtD
Prednisone—Convulsion—Methotrexate—bone cancer	8.09e-05	0.00107	CcSEcCtD
Prednisone—Malnutrition—Doxorubicin—bone cancer	8.08e-05	0.00107	CcSEcCtD
Prednisone—Erythema—Doxorubicin—bone cancer	8.08e-05	0.00107	CcSEcCtD
Prednisone—Anaemia—Epirubicin—bone cancer	8.08e-05	0.00107	CcSEcCtD
Prednisone—Agitation—Epirubicin—bone cancer	8.03e-05	0.00107	CcSEcCtD
Prednisone—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	7.95e-05	0.0147	CbGpPWpGaD
Prednisone—Arthralgia—Methotrexate—bone cancer	7.95e-05	0.00106	CcSEcCtD
Prednisone—Myalgia—Methotrexate—bone cancer	7.95e-05	0.00106	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	7.89e-05	0.00105	CcSEcCtD
Prednisone—Malaise—Epirubicin—bone cancer	7.88e-05	0.00105	CcSEcCtD
Prednisone—Discomfort—Methotrexate—bone cancer	7.85e-05	0.00104	CcSEcCtD
Prednisone—Vertigo—Epirubicin—bone cancer	7.85e-05	0.00104	CcSEcCtD
Prednisone—Syncope—Epirubicin—bone cancer	7.83e-05	0.00104	CcSEcCtD
Prednisone—Loss of consciousness—Epirubicin—bone cancer	7.68e-05	0.00102	CcSEcCtD
Prednisone—Anaphylactic shock—Methotrexate—bone cancer	7.62e-05	0.00101	CcSEcCtD
Prednisone—Vision blurred—Doxorubicin—bone cancer	7.62e-05	0.00101	CcSEcCtD
Prednisone—Convulsion—Epirubicin—bone cancer	7.57e-05	0.001	CcSEcCtD
Prednisone—Infection—Methotrexate—bone cancer	7.57e-05	0.001	CcSEcCtD
Prednisone—Hypertension—Epirubicin—bone cancer	7.54e-05	0.001	CcSEcCtD
Prednisone—Ill-defined disorder—Doxorubicin—bone cancer	7.5e-05	0.000996	CcSEcCtD
Prednisone—Nervous system disorder—Methotrexate—bone cancer	7.47e-05	0.000992	CcSEcCtD
Prednisone—Anaemia—Doxorubicin—bone cancer	7.47e-05	0.000992	CcSEcCtD
Prednisone—Arthralgia—Epirubicin—bone cancer	7.44e-05	0.000987	CcSEcCtD
Prednisone—Myalgia—Epirubicin—bone cancer	7.44e-05	0.000987	CcSEcCtD
Prednisone—Agitation—Doxorubicin—bone cancer	7.43e-05	0.000986	CcSEcCtD
Prednisone—Anxiety—Epirubicin—bone cancer	7.41e-05	0.000984	CcSEcCtD
Prednisone—Skin disorder—Methotrexate—bone cancer	7.4e-05	0.000982	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	7.39e-05	0.000981	CcSEcCtD
Prednisone—Hyperhidrosis—Methotrexate—bone cancer	7.37e-05	0.000978	CcSEcCtD
Prednisone—Discomfort—Epirubicin—bone cancer	7.35e-05	0.000976	CcSEcCtD
Prednisone—Malaise—Doxorubicin—bone cancer	7.29e-05	0.000968	CcSEcCtD
Prednisone—Vertigo—Doxorubicin—bone cancer	7.26e-05	0.000964	CcSEcCtD
Prednisone—Anorexia—Methotrexate—bone cancer	7.26e-05	0.000964	CcSEcCtD
Prednisone—Syncope—Doxorubicin—bone cancer	7.25e-05	0.000962	CcSEcCtD
Prednisone—Anaphylactic shock—Epirubicin—bone cancer	7.13e-05	0.000947	CcSEcCtD
Prednisone—Oedema—Epirubicin—bone cancer	7.13e-05	0.000947	CcSEcCtD
Prednisone—Loss of consciousness—Doxorubicin—bone cancer	7.11e-05	0.000943	CcSEcCtD
Prednisone—Infection—Epirubicin—bone cancer	7.08e-05	0.00094	CcSEcCtD
Prednisone—Shock—Epirubicin—bone cancer	7.02e-05	0.000931	CcSEcCtD
Prednisone—Convulsion—Doxorubicin—bone cancer	7e-05	0.00093	CcSEcCtD
Prednisone—Nervous system disorder—Epirubicin—bone cancer	6.99e-05	0.000928	CcSEcCtD
Prednisone—Hypertension—Doxorubicin—bone cancer	6.98e-05	0.000927	CcSEcCtD
Prednisone—Tachycardia—Epirubicin—bone cancer	6.96e-05	0.000924	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Methotrexate—bone cancer	6.94e-05	0.000922	CcSEcCtD
Prednisone—Skin disorder—Epirubicin—bone cancer	6.93e-05	0.000919	CcSEcCtD
Prednisone—Hyperhidrosis—Epirubicin—bone cancer	6.89e-05	0.000915	CcSEcCtD
Prednisone—Insomnia—Methotrexate—bone cancer	6.89e-05	0.000915	CcSEcCtD
Prednisone—Arthralgia—Doxorubicin—bone cancer	6.88e-05	0.000914	CcSEcCtD
Prednisone—Myalgia—Doxorubicin—bone cancer	6.88e-05	0.000914	CcSEcCtD
Prednisone—Anxiety—Doxorubicin—bone cancer	6.86e-05	0.00091	CcSEcCtD
Prednisone—Paraesthesia—Methotrexate—bone cancer	6.84e-05	0.000908	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	6.83e-05	0.000907	CcSEcCtD
Prednisone—Discomfort—Doxorubicin—bone cancer	6.8e-05	0.000903	CcSEcCtD
Prednisone—Anorexia—Epirubicin—bone cancer	6.8e-05	0.000902	CcSEcCtD
Prednisone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—bone cancer	6.74e-05	0.0124	CbGpPWpGaD
Prednisone—Dyspepsia—Methotrexate—bone cancer	6.71e-05	0.00089	CcSEcCtD
Prednisone—NR3C1—Generic Transcription Pathway—ZNF77—bone cancer	6.69e-05	0.0123	CbGpPWpGaD
Prednisone—NR3C1—Endoderm Differentiation—EZH2—bone cancer	6.68e-05	0.0123	CbGpPWpGaD
Prednisone—Decreased appetite—Methotrexate—bone cancer	6.62e-05	0.000879	CcSEcCtD
Prednisone—Anaphylactic shock—Doxorubicin—bone cancer	6.6e-05	0.000876	CcSEcCtD
Prednisone—Oedema—Doxorubicin—bone cancer	6.6e-05	0.000876	CcSEcCtD
Prednisone—Fatigue—Methotrexate—bone cancer	6.57e-05	0.000872	CcSEcCtD
Prednisone—Infection—Doxorubicin—bone cancer	6.55e-05	0.00087	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Epirubicin—bone cancer	6.5e-05	0.000862	CcSEcCtD
Prednisone—Shock—Doxorubicin—bone cancer	6.49e-05	0.000862	CcSEcCtD
Prednisone—Nervous system disorder—Doxorubicin—bone cancer	6.47e-05	0.000859	CcSEcCtD
Prednisone—Insomnia—Epirubicin—bone cancer	6.45e-05	0.000856	CcSEcCtD
Prednisone—Tachycardia—Doxorubicin—bone cancer	6.44e-05	0.000855	CcSEcCtD
Prednisone—Skin disorder—Doxorubicin—bone cancer	6.41e-05	0.000851	CcSEcCtD
Prednisone—Paraesthesia—Epirubicin—bone cancer	6.4e-05	0.00085	CcSEcCtD
Prednisone—Hyperhidrosis—Doxorubicin—bone cancer	6.38e-05	0.000847	CcSEcCtD
Prednisone—Dexamethasone—CYP3A4—bone cancer	6.35e-05	0.0214	CrCbGaD
Prednisone—Anorexia—Doxorubicin—bone cancer	6.29e-05	0.000835	CcSEcCtD
Prednisone—Feeling abnormal—Methotrexate—bone cancer	6.28e-05	0.000833	CcSEcCtD
Prednisone—Dyspepsia—Epirubicin—bone cancer	6.28e-05	0.000833	CcSEcCtD
Prednisone—Gastrointestinal pain—Methotrexate—bone cancer	6.23e-05	0.000827	CcSEcCtD
Prednisone—Dexamethasone—PTGS2—bone cancer	6.21e-05	0.0209	CrCbGaD
Prednisone—Decreased appetite—Epirubicin—bone cancer	6.2e-05	0.000823	CcSEcCtD
Prednisone—Fatigue—Epirubicin—bone cancer	6.15e-05	0.000816	CcSEcCtD
Prednisone—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	6.12e-05	0.0113	CbGpPWpGaD
Prednisone—Constipation—Epirubicin—bone cancer	6.1e-05	0.000809	CcSEcCtD
Prednisone—Urticaria—Methotrexate—bone cancer	6.05e-05	0.000804	CcSEcCtD
Prednisone—Body temperature increased—Methotrexate—bone cancer	6.02e-05	0.0008	CcSEcCtD
Prednisone—Abdominal pain—Methotrexate—bone cancer	6.02e-05	0.0008	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Doxorubicin—bone cancer	6.01e-05	0.000798	CcSEcCtD
Prednisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	6e-05	0.0111	CbGpPWpGaD
Prednisone—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	5.98e-05	0.011	CbGpPWpGaD
Prednisone—Insomnia—Doxorubicin—bone cancer	5.97e-05	0.000792	CcSEcCtD
Prednisone—Paraesthesia—Doxorubicin—bone cancer	5.92e-05	0.000786	CcSEcCtD
Prednisone—Feeling abnormal—Epirubicin—bone cancer	5.88e-05	0.00078	CcSEcCtD
Prednisone—Gastrointestinal pain—Epirubicin—bone cancer	5.83e-05	0.000774	CcSEcCtD
Prednisone—Dyspepsia—Doxorubicin—bone cancer	5.81e-05	0.000771	CcSEcCtD
Prednisone—Decreased appetite—Doxorubicin—bone cancer	5.74e-05	0.000761	CcSEcCtD
Prednisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	5.69e-05	0.0105	CbGpPWpGaD
Prednisone—Fatigue—Doxorubicin—bone cancer	5.69e-05	0.000755	CcSEcCtD
Prednisone—Urticaria—Epirubicin—bone cancer	5.66e-05	0.000752	CcSEcCtD
Prednisone—Constipation—Doxorubicin—bone cancer	5.64e-05	0.000749	CcSEcCtD
Prednisone—Abdominal pain—Epirubicin—bone cancer	5.64e-05	0.000748	CcSEcCtD
Prednisone—Body temperature increased—Epirubicin—bone cancer	5.64e-05	0.000748	CcSEcCtD
Prednisone—Hypersensitivity—Methotrexate—bone cancer	5.61e-05	0.000745	CcSEcCtD
Prednisone—Asthenia—Methotrexate—bone cancer	5.47e-05	0.000726	CcSEcCtD
Prednisone—Feeling abnormal—Doxorubicin—bone cancer	5.44e-05	0.000722	CcSEcCtD
Prednisone—Gastrointestinal pain—Doxorubicin—bone cancer	5.39e-05	0.000716	CcSEcCtD
Prednisone—Pruritus—Methotrexate—bone cancer	5.39e-05	0.000716	CcSEcCtD
Prednisone—Hypersensitivity—Epirubicin—bone cancer	5.25e-05	0.000697	CcSEcCtD
Prednisone—Urticaria—Doxorubicin—bone cancer	5.24e-05	0.000696	CcSEcCtD
Prednisone—Abdominal pain—Doxorubicin—bone cancer	5.22e-05	0.000692	CcSEcCtD
Prednisone—Body temperature increased—Doxorubicin—bone cancer	5.22e-05	0.000692	CcSEcCtD
Prednisone—Diarrhoea—Methotrexate—bone cancer	5.21e-05	0.000692	CcSEcCtD
Prednisone—Asthenia—Epirubicin—bone cancer	5.12e-05	0.000679	CcSEcCtD
Prednisone—Pruritus—Epirubicin—bone cancer	5.04e-05	0.00067	CcSEcCtD
Prednisone—Dizziness—Methotrexate—bone cancer	5.04e-05	0.000669	CcSEcCtD
Prednisone—Diarrhoea—Epirubicin—bone cancer	4.88e-05	0.000648	CcSEcCtD
Prednisone—Hypersensitivity—Doxorubicin—bone cancer	4.86e-05	0.000645	CcSEcCtD
Prednisone—Vomiting—Methotrexate—bone cancer	4.84e-05	0.000643	CcSEcCtD
Prednisone—Rash—Methotrexate—bone cancer	4.8e-05	0.000638	CcSEcCtD
Prednisone—Dermatitis—Methotrexate—bone cancer	4.8e-05	0.000637	CcSEcCtD
Prednisone—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	4.78e-05	0.00882	CbGpPWpGaD
Prednisone—Headache—Methotrexate—bone cancer	4.77e-05	0.000634	CcSEcCtD
Prednisone—Asthenia—Doxorubicin—bone cancer	4.73e-05	0.000628	CcSEcCtD
Prednisone—Dizziness—Epirubicin—bone cancer	4.72e-05	0.000626	CcSEcCtD
Prednisone—Pruritus—Doxorubicin—bone cancer	4.67e-05	0.00062	CcSEcCtD
Prednisone—Vomiting—Epirubicin—bone cancer	4.53e-05	0.000602	CcSEcCtD
Prednisone—Nausea—Methotrexate—bone cancer	4.53e-05	0.000601	CcSEcCtD
Prednisone—Diarrhoea—Doxorubicin—bone cancer	4.51e-05	0.000599	CcSEcCtD
Prednisone—ALB—Folate Metabolism—DHFR—bone cancer	4.51e-05	0.00832	CbGpPWpGaD
Prednisone—Rash—Epirubicin—bone cancer	4.5e-05	0.000597	CcSEcCtD
Prednisone—Dermatitis—Epirubicin—bone cancer	4.49e-05	0.000596	CcSEcCtD
Prednisone—Headache—Epirubicin—bone cancer	4.47e-05	0.000593	CcSEcCtD
Prednisone—Dizziness—Doxorubicin—bone cancer	4.36e-05	0.000579	CcSEcCtD
Prednisone—HSD11B1—Metabolism—ENO2—bone cancer	4.34e-05	0.00801	CbGpPWpGaD
Prednisone—Nausea—Epirubicin—bone cancer	4.24e-05	0.000562	CcSEcCtD
Prednisone—Vomiting—Doxorubicin—bone cancer	4.19e-05	0.000557	CcSEcCtD
Prednisone—Rash—Doxorubicin—bone cancer	4.16e-05	0.000552	CcSEcCtD
Prednisone—Dermatitis—Doxorubicin—bone cancer	4.16e-05	0.000552	CcSEcCtD
Prednisone—Headache—Doxorubicin—bone cancer	4.13e-05	0.000549	CcSEcCtD
Prednisone—HSD11B1—Metabolism—DHFR—bone cancer	4.03e-05	0.00743	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—SPARC—bone cancer	3.95e-05	0.00729	CbGpPWpGaD
Prednisone—Nausea—Doxorubicin—bone cancer	3.92e-05	0.00052	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—PLAU—bone cancer	3.9e-05	0.00719	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—GNA11—bone cancer	3.77e-05	0.00695	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	3.76e-05	0.00694	CbGpPWpGaD
Prednisone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	3.7e-05	0.00683	CbGpPWpGaD
Prednisone—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	3.65e-05	0.00674	CbGpPWpGaD
Prednisone—NR3C1—Regulation of Androgen receptor activity—MDM2—bone cancer	3.41e-05	0.0063	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—CYP3A4—bone cancer	3.41e-05	0.0063	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.4e-05	0.00626	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	3.28e-05	0.00605	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—ZNF77—bone cancer	3.22e-05	0.00594	CbGpPWpGaD
Prednisone—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	3e-05	0.00554	CbGpPWpGaD
Prednisone—NR3C1—Regulation of Androgen receptor activity—JUN—bone cancer	2.97e-05	0.00547	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—GSTP1—bone cancer	2.92e-05	0.00539	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.79e-05	0.00514	CbGpPWpGaD
Prednisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	2.48e-05	0.00457	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—bone cancer	2.41e-05	0.00444	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.41e-05	0.00444	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—JUN—bone cancer	2.38e-05	0.00438	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—MMP9—bone cancer	2.31e-05	0.00426	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—NR1I2—bone cancer	2.26e-05	0.00418	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—NDUFA12—bone cancer	2.18e-05	0.00402	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	2.11e-05	0.0039	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—JUN—bone cancer	2.09e-05	0.00386	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	2.03e-05	0.00374	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—RB1—bone cancer	1.95e-05	0.0036	CbGpPWpGaD
Prednisone—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	1.9e-05	0.0035	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—NT5C3A—bone cancer	1.81e-05	0.00333	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	1.75e-05	0.00323	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	1.73e-05	0.00318	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	1.6e-05	0.00296	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—CYP3A4—bone cancer	1.59e-05	0.00294	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—FUS—bone cancer	1.57e-05	0.0029	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	1.57e-05	0.0029	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	1.57e-05	0.0029	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—TP53—bone cancer	1.57e-05	0.00289	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PTGS2—bone cancer	1.51e-05	0.00279	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	1.45e-05	0.00268	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	1.43e-05	0.00264	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	1.41e-05	0.0026	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—bone cancer	1.38e-05	0.00255	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—GSTP1—bone cancer	1.36e-05	0.00252	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.36e-05	0.00251	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	1.35e-05	0.00248	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	1.34e-05	0.00248	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	1.34e-05	0.00247	CbGpPWpGaD
Prednisone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	1.27e-05	0.00233	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—JUN—bone cancer	1.25e-05	0.00231	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	1.2e-05	0.00221	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.19e-05	0.0022	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.18e-05	0.00217	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NR1I2—bone cancer	1.09e-05	0.00201	CbGpPWpGaD
Prednisone—ALB—Metabolism—NDUFA12—bone cancer	1.06e-05	0.00196	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.03e-05	0.0019	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TP53—bone cancer	1.01e-05	0.00186	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NDUFA12—bone cancer	9.56e-06	0.00176	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NDUFA12—bone cancer	9.33e-06	0.00172	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SPARC—bone cancer	9.03e-06	0.00167	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	8.87e-06	0.00164	CbGpPWpGaD
Prednisone—ALB—Metabolism—NT5C3A—bone cancer	8.82e-06	0.00163	CbGpPWpGaD
Prednisone—ALB—Hemostasis—GNA11—bone cancer	8.26e-06	0.00152	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—GSTP1—bone cancer	8.2e-06	0.00151	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	8.09e-06	0.00149	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—EIF2S1—bone cancer	8.05e-06	0.00149	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NT5C3A—bone cancer	7.92e-06	0.00146	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ENO2—bone cancer	7.91e-06	0.00146	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NT5C3A—bone cancer	7.73e-06	0.00143	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IL3—bone cancer	7.49e-06	0.00138	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—DHFR—bone cancer	7.34e-06	0.00135	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—EZH2—bone cancer	7e-06	0.00129	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GNA11—bone cancer	6.86e-06	0.00126	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	6.58e-06	0.00121	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	6.34e-06	0.00117	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP3A4—bone cancer	6.22e-06	0.00115	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.18e-06	0.00114	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NDUFA12—bone cancer	5.75e-06	0.00106	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	5.72e-06	0.00105	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTP1—bone cancer	5.32e-06	0.000981	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PLAU—bone cancer	4.91e-06	0.000906	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NT5C3A—bone cancer	4.76e-06	0.000878	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.49e-06	0.000829	CbGpPWpGaD
Prednisone—ALB—Metabolism—ENO2—bone cancer	3.86e-06	0.000713	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.77e-06	0.000696	CbGpPWpGaD
Prednisone—ALB—Metabolism—DHFR—bone cancer	3.58e-06	0.000661	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ENO2—bone cancer	3.47e-06	0.00064	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ENO2—bone cancer	3.39e-06	0.000624	CbGpPWpGaD
Prednisone—ALB—Metabolism—GNA11—bone cancer	3.35e-06	0.000618	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—DHFR—bone cancer	3.22e-06	0.000594	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—DHFR—bone cancer	3.14e-06	0.000579	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP3A4—bone cancer	3.04e-06	0.00056	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.02e-06	0.000557	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GNA11—bone cancer	3.01e-06	0.000555	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GNA11—bone cancer	2.94e-06	0.000541	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS2—bone cancer	2.75e-06	0.000508	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP3A4—bone cancer	2.73e-06	0.000503	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.71e-06	0.0005	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP3A4—bone cancer	2.66e-06	0.000491	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTP1—bone cancer	2.6e-06	0.000479	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTP1—bone cancer	2.33e-06	0.00043	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTP1—bone cancer	2.28e-06	0.00042	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ENO2—bone cancer	2.09e-06	0.000385	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—bone cancer	1.98e-06	0.000364	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—DHFR—bone cancer	1.93e-06	0.000357	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GNA11—bone cancer	1.81e-06	0.000334	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTP1—bone cancer	1.4e-06	0.000259	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS2—bone cancer	1.35e-06	0.000248	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS2—bone cancer	1.21e-06	0.000223	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS2—bone cancer	1.18e-06	0.000217	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS2—bone cancer	7.26e-07	0.000134	CbGpPWpGaD
